BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, March 13, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 8, 2012
View Archived Issues
Skuldtech and AB Science identify new markers for pancreatic cancer survival
Read More
Eisai: second quarter of fiscal 2012 in review
Read More
Avaxia Biologics presents promising in vivo results for AVX-470m
Read More
Astellas Pharma presents overview of second quarter of fiscal 2012
Read More
Promising results reported from phase IIa trial of UISH-001
Read More
Two phase III trials of Epanova meet primary and secondary endpoints
Read More
FDA approves Pfizer's Xeljanz for rheumatoid arthritis
Read More
Takeda Pharmaceutical reviews accomplishments of second quarter of fiscal 2012
Read More
GlaxoSmithKline reports highlights of third quarter 2012
Read More
Novel strategies for lipid management: SOAT inhibitor PRD-017
Read More
Aspireo Pharmaceuticals begins phase IIa trial of Somatoprim
Read More
Novartis files for approval of QVA-149 in Japan
Read More
Cardiovascular benefits demonstrated for SIRT1 activator SRT-2104 in smokers
Read More
Bayer presents new protein kinase Akt inhibitors for cancer
Read More
Bristol-Myers Squibb patents new lysophospholipid receptor antagonists
Read More
Aileron Therapeutics develops new oncology drug candidate
Read More
Phase I trial of SMT-C1100 meets endpoints
Read More
Takeda Pharmaceutical synthesizes novel ionotropic glutamate receptor agonists
Read More
First patient enrolled in phase I/IIa trial of PAT-SM6
Read More
FDA advisory committee votes in favor of raxibacumab
Read More
Novel gamma-secretase inhibitors disclosed by Merck & Co.
Read More
FDA grants priority review to trastuzumab emtansine NDA
Read More
MorphoSys and Novartis expand antibody alliance
Read More
Pfizer patents novel Trk inhibitors for the treatment of pain
Read More
Cadila Pharmaceuticals presents clinical results for CADI-05 in bladder cancer
Read More
New nNOS inhibitors presented by Northwestern University
Read More
